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ABSTRACT
Marine sponges have been the source of various metabolites with potent biological activities. In this study fifteen methanolic
extracts of marine sponges, collected off the coast of Tabuhan Island, Banyuwangi, East Java, Indonesia were evaluated in
relation to their cholinesterase and 5α-reductase inhibitory activities. The results revealed that the extract of Petrosia sp.
inhibited the 5α-reductase enzyme at 100 µg/mL, with 61.21% inhibition, which is slightly lower than the positive control,
finasteride, of 76.70%. The results of the cholinesterase inhibitory screening showed that three marine sponges namely,
Callyspongia sp., Niphates olemda, and Agelas nakamurai presented notable cholinesterase inhibitory activities. The highest
potency was found in A. nakamurai, with an IC50 value of 1.05 µg/mL. All three samples inhibited both acetylcholinesterase
(AChE) and butyrylcholinesterase (BuChE), however, the extract of N. olemda showed a higher inhibition against AChE
compared to BuChE. The chemistry of the Callyspongia sp., N. olemda and A. nakamurai were investigated using thin layer
chromatography and 1H NMR methods. The results suggested the presence of terpenes and alkaloids in the samples. Further
study is needed to determine the metabolite responsible for cholinesterase inhibitory activity.
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INTRODUCTION
Oceans, which cover almost two-thirds of the Earth’s
surface, have been the habitat of various living
creatures, including algae, sponges, cnidarians,
mollusks, bryozoans, ascidians and echinoderms as
well as microorganisms (Costello et al., 2010). This
species diversity makes the marine environment one
of the most prolific sources of natural products.
More than 20,000 natural compounds have been
discovered from various marine organisms (El
Gamal, 2010). Many of these marine creatures
produce unique and biologically active compounds,
which are not found in the terrestrial ecosystem
(Thakur et al., 2005; Harvey, 2008; Molinski et al.,
2009).
Enzyme inhibitors have played important roles
in the development of natural compounds for
pharmacological and agricultural applications.
Terrestrial and marine organisms have been reported
as the source of enzyme inhibitors (Ruocco et al.,
2017). Examples of target enzymes for biological
screening include cholinesterase and 5α-reductase.
Cholinesterase is present in the human central
nervous system and is involved in the hydrolysis
of acetylcholine (ACh) to choline and ethanoic acid.
ACh is a neurotransmitter, produced in the nerve
ending of the presynaptic nerve, which is asso-
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ciated with memory and cognitive functions
(Houghton et al., 2006; Dev & Maurya, 2017). ACh
deficiency is a common feature in a patient with
Alzheimer’s disease (AD), therefore, the inhibition
of cholinesterase is one of the strategies for the
treatment of AD. Example of approved AChE drugs,
including tacrine, rivastigmine, physostigmine and
galantamine, however, there is the limitation of these
drugs, for example, short half-life, side effect such
as hepatotoxicity as well as the loss of drug efficacy
(Nukoolkarn et al., 2008; Farrokhnia & Nabipour,
2014). Therefore, the search for more potent and
safe cholinesterase inhibitor has been desirable.
Galantamine and rivastigmine are examples of
naturally derived acetylcholinesterase inhibitors,
which have inspired more research on more potent
AChE inhibitors from natural sources, including
marine organisms. Several marine sponge com-
pounds have also been reported to inhibit AChE
enzymes, such as a steroidal alkaloid from Corticium
sp. (Langje et al., 2007), pyridoacridine alkaloid
petrosamine, isolated from Petrosia sp., which
was predicted to bind to the TcACHE enzyme
(Nukoolkarn et al., 2008), pyridinium alkaloids from
Reniera sarai and from a genus Plakortis (Alonso
et al., 2005; Turk et al., 2007; Kubota et al., 2010),
a bis-indole alkaloid from Fascaplysinopsis sp.
(Bharate et al., 2012), and a bromopyrolle alkaloid
isolated from Agelas oroides (Erdogan-Orhan et al.,
2012).
A 5α-reductase is an enzyme responsible for
the conversion of testosterone, the main androgen
in humans, to dihydrotestosterone (DHT), a more
potent androgen. The excessive production of DHT
may cause androgen dependent disorders. The
characteristics of these diseases include androgenic
alopecia (male pattern baldness), acne, benign
prostate hyperplasia (BPH) and female hirsutism
(Tsukamoto et al., 1998; Suphrom et al., 2012;
Srivilai et al., 2016). An antiandrogen is a com-
pound that can block or suppress the action of the
male sex hormone, such as testosterone or DHT. One
of the antiandrogen mechanisms is the inhibition of
the 5α-reductase enzyme so that the conversion of
testosterone to DHT is blocked. This 5α-reductase
inhibitor acts selectively inside its target cells,
therefore, it does not lower the serum concentration
of testosterone and causes almost no adverse
reactions, such as the reduction of libido (Grant
& Ramasamy, 2012). The use of 5α-reductase
inhibitors, such as finasteride which has been
approved by the United States FDA, for treatment
of BPH, however, may cause side effect i.e
gynecomastia, impairment of muscle growth, and
severe myopathy (Aggarwal et al., 2010). Therefore,
the search for a more potent and selective
antiandrogen is needed.
Several plant metabolites have been reported as
5α-reductase inhibitors (Seo et al., 2002; Suphrom
et al., 2012; Srivilai et al., 2016; Grant et al., 2012),
however, there are limited reports of marine derived
compounds that target this enzyme. The objective
of the current study is to investigate the inhibitory
activity of fifteen marine sponges, derived from
Tabuhan Island, Banyuwangi, East Java, Indonesia,
against cholinesterase and 5α-reductase enzymes.
MATERIALS AND METHODS
Reagents
Acetylcholinesterase from electric eel (AChE
typeVI-S, EeAChE), human recombinant acetylcho-
linesterase (hrAChE), horse-serum butyrylcho-
linesterase (BuChE), acetylthiocholine iodide
(ATCI), 5,51-d:thiobs[2-nitrobenzoic acid] (DTNB),
and bovine serum albumin (BSA), trisma base-HCl
buffer (Tris buffer), galantamine and finasteride,
reagents were obtained from Sigma-Aldrich. Crude
enzyme 5α-reductase was prepared from androgen-
dependent LNCaP cells (CRL-1740TM from
American Type Culture Collection, VA, USA). The
cell was cultured in a medium RPMI-1640,
supplemented with 10% fetal bovine serum, 100
U/mL penicillin G and 100 µg/mL streptomycin
(Gibco, Paisley, Scotland).
Sponge collection and extraction
Marine sponges were collected from the
Tabuhan Island dive site, Banyuwangi, East Java,
Indonesia using SCUBA at a depth of 10-20 m
on 23 April 2017. Fresh sponges were taken to the
laboratory and stored at -20°C until extraction.
Voucher specimens were preserved in alcohol and
deposited at the Department of Pharmacognosy and
Phytochemistry, Faculty of Pharmacy, Universitas
Airlangga, Surabaya, Indonesia. Identification of
the sponges was conducted by Dr. Tri Aryono Hadi
of Research Center of Oceanography, Indonesian
Institute of Sciences, Jakarta, Indonesia. Fresh
sponges were diced and lyophilized. The dry sponge
materials were then grounded and extracted
exhaustively with methanol to produce the crude
methanolic extracts.
Cholinesterase inhibitory assay
The assay was carried out according to the
modified Ellman’s method (Ellman et al., 1961;
Ingkaninan et al., 2003; Sirimangkalakitti et al.,
2015). Sponge extracts were dissolved in 50 mM
Tris buffer containing not more than 10% MeOH
to obtain a 1 mg/mL concentration, and these were
further diluted in the microplate well to a final test
concentration of 100 µg/mL. Sample solutions were
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added to a 96-well microplate, followed by the
addition of 1.5 mM ATCI (25 µL, 3 mM DTNB (125
µL), and Tris buffer (50 µL). The substrate was then
hydrolyzed by the addition of 25 µL of 0.28 U/mL
of either EeAChE, hrAChE or BuChE.The solutions
were shaken for 30 s in a microplate reader (Bio-Tek
Instrument, USA) before measurement. The product,
5-thio-2-nitrobenzoate, indicated by a yellow color
was measured at 405 nm every 17 s for 2.29 min.
Every experiment was carried out in triplicate.
Galantamine was used as a positive control, and
10% methanol was used as a negative control. For
the measurement of IC50, serial concentrations of the
samples were prepared. The enzyme activity was
calculated as a percentage of the velocity of the test
sample, compared with that of the non-treated
control. The inhibitory activity was calculated as:
% Inhibition = [(Mean velocity of control – Mean
velocity of sample) / Mean velocity of control] × 100
5α-Reductase assay
The 5α-reductase inhibitory activity was carried
out by the method of Srivilai et al. (2016). The
enzymatic assay was performed in a 96-well plate.
The final test solution (200 µL) contained 10 µL of
test samples dissolved in DMSO, 34.74 µM
testosterone, 1 mM NADPH, homogenized crude
enzyme (75 µg protein) and Tris buffer pH 7.4. The
mixture was incubated at 37°C for 60 min. Then,
300 µL hydroxylamine (10 mg/mL in 80% ethanol)
was added and further incubated at 60°C for 60 min.
The plate was then centrifuged at 1700 g for 10 min.
The supernatant was collected and injected into
LC-MS for the determination of DHT production.
The DHT production was determined by LC-
ESI-QTOF-MS (Agilent 1260 infinity series
connected with Agilent 6540 UHD accurate-mass
Q-TOF LC/MS). The Phenomenex Luna® C-18 (150
x 4.6 mm, 5 µm) column was used as a stationary
phase. The mobile phase was 0.1% v/v formic acid
in purified water (solvent A) and 0.1% v/v formic
acid in acetonitrile (solvent B), gradient elution
starting from 40% solvent A and 60% solvent B,
then solvent B increase to 80% (8 mins), followed
by isocratic 80% solvent B for 4 mins, with a flow
rate of 0.5 mL/min. The column temperature was
set to 35°C, and the sample injection volume was
20 µL. The extracted ion chromatogram of the
derivatized-DHT (m/z [M+H]+ 306.2428) was
observed. The peak area was used to calculate the
inhibitory activity as shown in the equation below:
Enzymatic inhibition (%) = [1-(sample-control0min)/
(control60min – control0min)] × 100
Phytochemical Screening
Thin layer chromatography was performed on
silica gel 60 F254 plates as a stationary phase, and
ethyl acetate: methanol (1:1) as mobile phase.
Visualization was carried out using anisaldehyde-
H2SO4 (terpene) or Dragendorff (alkaloid). The 1H
NMR spectra were recorded in a JEOL 400 MHz
NMR instrument using CDCl3 as a solvent.
Data analysis
The 50% inhibitory concentration (IC50) was
determined using GraphPad Prism 6.0 software by
plotting log concentrations as axis and % inhibition
as ordinate. The inhibition data of the samples
against AChE and BuChE were analyzed using




Fifteen marine sponges were collected from the
Tabuhan Island dive site, Banyuwangi, Indonesia.
The methanolic extracts of the sponges were
subjected to both cholinesterase and 5α-reductase
inhibitory assays. The results presented in Table 1
showed that at 100 µg/mL three sponges, namely,
Callyspongia sp., Niphates olemda and Agelas
nakamurai, strongly inhibited the AChE enzyme,
with a percentage inhibition of 97.16, 91.89 and
85.67%, respectively. The methanolic extracts of
Axynissa sp. and Stylissa carteri showed 30-50%
inhibitory activity, while the rest of the extracts
presented an inhibition of below 10%. The dose-
dependent inhibitory activity of the three active
extracts (Callyspongia sp., N. olemda, and A.
nakamurai) were further investigated using the
human recombinant AChE (hrAChE) enzyme. The
results are presented in Figure 1, and the IC50 values
are tabulated in Table 3. It was found that among
the three samples tested, the methanolic extract of
A. nakamurai had the highest potency with an IC50
value of 1.05 µg/mL, while the other two extracts,
Callyspongia sp. and N. olemda, presented IC50
values of 14.69 and 56.78 µg/mL, respectively. The
IC50 value of the A. nakamurai extract is slightly
higher than that of the positive control galantamine
(0.63 µg/mL).
The three samples were then screened against
butyrylcholinesterase (BuChE) in order to investi-
gate the selectivity. The results shown in Table 2
suggested that the methanolic extracts of
Callyspongia sp., N. olemda and A. nakamurai
inhibited both the AChE and BuChE enzyme.
However, the extract of N. olemda showed a lower
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Table 1. The inhibitory activities of the methanolic extracts of marine sponges
against acetylcholinesterase (AChE) and 5α-reductase (5αR)
Samples % AChE Inhibition % 5αR Inhibiton
Callyspongia sp. 97.16 ± 0.93 57.72 ± 5.27
Clathria (Thalysias) reinwardtii < 10 45.20 ± 2.71
Niphates olemda 91.89 ± 0.17 57.65 ± 1.50
Haliclona (Reniera) fascigera < 10 22.25 ± 9.12
Clathria (Clathria) basilana < 10 31.52 ± 4.45
Acanthella cavernosa < 10 < 10
Agelas nakamurai 85.67 ± 0.76 < 10
Niphates sp. < 10 28.04 ± 4.00
Petrosia (Petrosia) hoeksemai <10 39.18 ± 4.87
Petrosia (Petrosia) sp. < 10 61.21 ± 3.81
Axynissa sp. 31.04 ± 0.47 27.54 ± 8.65
Coelocarteria agglomerans < 10 52.23 ± 8.81
Ulosa ada < 10 52.46 ± 7.86
Stylissa carteri 49.00 ± 2.34 29.01 ± 5.63
Cinachryrella sp. < 10 < 10
Galantamine 98.44 ± 0.59
Finasteride 76.70 ± 8.71
Data presented as mean ± SD of three independent experiments, each done in triplicate.
Samples were tested at 100 µg/mL. Galantamine and finasteride were tested at 100 µM
(36.83 µg/mL) and 8 µM (2.98 µg/mL), respectively.
Fig. 1. Dose-dependent response of selected marine sponges to the inhibition of
acetylcholinesterase. Data presented as mean ± standard deviation of three independent
experiments.
Table 2. Comparison of inhibitory activities of selected marine sponge extracts
against acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE)
Samples % AChE Inhibition % BuChE Inhibiton
Callyspongia sp. 97.16 ± 0.93 93.65 ± 0.13
Niphates olemda 91.89 ± 0.17 73.30 ± 0.55
Agelas nakamurai 85.67 ± 0.76 94.92 ± 0.93
Galantamine 98.44 ± 0.59 90.94 ± 0.15
Data presented as mean ± standard deviation of three independent experiments, each done
in triplicate. Samples were tested at 100 µg/mL. Galantamine was tested at 100 µM (36.83
µg/mL).
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inhibition against BuChE, compared to AChE
enzyme. The inhibition data of the three samples
against AChE and BuChE were then analyzed using
IBM SPSS statistics 21 software. A comparison of
each sample’s activities against AChE and BuChE
were conducted using independent-sample T-tests.
The results indicated that there is a significant
difference observed between the inhibition of the
N. olemda extract against AChE and BuChE
(p-value < 0.001), while there are no significant
differences observed between the extracts of
Callyspongia sp. and those of A. nakamurai against
AChE and BuChE (p-value >0.001).
5α-Reductase inhibitory activity
The methanolic extracts from the fifteen marine
sponges were also subjected to a 5α-reductase
inhibitory assay. Samples were tested at a
concentration of 100 µg/mL. Finasteride was used
as a positive control at a concentration of 8 µM
(2.98 µg/mL). The results (Table 1) showed that the
extract of Petrosia sp. had the highest inhibition at
61.21% compared to other tested samples, however,
it was lower than the activity of finasteride which
had inhibition of 76.70%. Four extracts, namely,
Callyspongia sp., N. olemda, C. agglomerans and
U. ada showed approximately 50% inhibition, while
the rest of the extract presented below 50%
inhibition.
Phytochemical screening
The chemical composition of the Callyspongia
sp. N. olemda and A. nakamurai were studied since
these three samples had a high inhibition against
the AChE enzyme. The screening was conducted
using thin layer chromatography (TLC) and 1H NMR
methods. The results indicated that the methanolic
extract of N. olemda contains terpene, as indicated
by the anisaldehyde sulphuric acid dye on the TLC
plates. This was further supported by 1H NMR,
which showed signals at δH 1.0-5.0 ppm which
corresponded to the presence of methyl, methylene,
and methine groups. The TLC and 1H NMR spectra
of the methanolic extracts of Callyspongia sp. and
A. nakamurai suggested the presence of alkaloid
and terpene. These findings are in agreement
with the data reported in the literature for
metabolites reported from Callyspongia sp., N.
olemda and A. nakamurai. Terpene compounds,
such as niphateolide A, which has been isolated
from N. olemda (Kato et al., 2015). Callyspongia
sp. has been reported to contain terpene such as
polyhydroxy isocoplane (Kurnianda et al., 2017)
and alkaloid such as callylactam A and callyimine
as well as diketopiperazine compounds (Yang et al.,
2013; Yang et al., 2016). Agelas nakamurai have
been reported to contain several terpenoids, such as
nakamurols A-D (Shoji et al., 1996), as well as
diterpene alkaloid agelasines (Hertiani et al., 2010;
Zhang et al., 2017; Chu et al., 2017). Hertiani et
al. (2010) have investigated the chemistry of
Indonesian Agelas nakamurai, collected from
Menjangan Island, north of the Bali Sea, and found
that a diterpene alkaloid, (–) agelasine D, was a
major compound in this marine sponge (Hertiani et
al., 2010). The 1H NMR spectrum of our sample of
A. nakamurai showed signals at δH 10.51, 8.45, 6.95
and 4.05 ppm which suggested the presence of
methyladenine moiety, as well as several signals
between δH 1.5-5.5 ppm corresponded to diterpene
moiety. These data are similar to those reported for
agelasine D. Further analyses should be undertaken
to confirm the presence of this compound in our
sample.
Several sponges from the genus Agelas have
shown anticholinesterase activity. The extract of
Agelas oroides, as well as the isolated bromopyrolle
alkaloid, oroidin, have been reported to have a
moderate AChE inhibitory activity. Agelas clathrodes
and Agelas marmarica have shown a moderate
inhibition against AChE (  et al., 2010;
Beedessee et al., 2013). The chemical constituents
of Petrosia sp. was not investigated in this study due
to the limited availability of sample. Several studies
reported that this sponge contains polyacetylenes
and sterols known to have anticancer activity (Kim
et al., 2002; Choi et al., 2004; Park et al., 2007;
Pailee et al., 2017). To the best of our knowledge,
there is no report on the AChE inhibitory activity
of Callyspongia sp., Niphates olemda and Agelas
nakamurai and 5α-reductase inhibitory activity of
Petrosia sp. Further study should be carried out to
investigate the metabolites responsible for this
enzyme inhibitory activity of the active samples.
CONCLUSION
Fifteen marine sponges were screened against
cholinesterase and 5α-reductase. The results
suggested that three sponge extracts, namely,
Callyspongia sp., Niphates olemda and Agelas
Table 3. IC50 values for the selected marine
sponge extracts against acetylcholinesterase
Samples IC50 (µg/mL)
Callyspongia sp. 14.69 ± 2.95
Niphates olemda 56.78 ± 2.53
Agelas nakamurai 1.05 ± 0.05
Galantamine 0.63 ± 0.05
Data presented as mean ± standard deviation of
three independent experiments, each done in
triplicate.
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nakamurai showed a high inhibition against the
AChE enzyme, and A. nakamurai had the highest
inhibition with an IC50 value of 1.05 µg/mL. The
methanolic extract of Petrosia sp. exhibited
61.21% inhibition against 5α-reductase. Further
study is needed to study the chemistry behind the
active samples.
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